139 related articles for article (PubMed ID: 124711)
1. Retinal capillary basement membrane thickness in spiny mice (Acomys cahirinus) with induced and spontaneous diabetes.
Beauchemin ML; Leuenberger PM; Babel J
Invest Ophthalmol; 1975 Jul; 14(7):560-2. PubMed ID: 124711
[TBL] [Abstract][Full Text] [Related]
2. Retinal capillary basement membrane thickening in a porcine model of diabetes mellitus.
Hainsworth DP; Katz ML; Sanders DA; Sanders DN; Wright EJ; Sturek M
Comp Med; 2002 Dec; 52(6):523-9. PubMed ID: 12540165
[TBL] [Abstract][Full Text] [Related]
3. Retinal capillary basement membrane thickness in diabetic mice genetically modified at the haptoglobin locus.
Miller-Lotan R; Miller B; Nakhoul F; Aronson D; Asaf R; Levy AP
Diabetes Metab Res Rev; 2007 Feb; 23(2):152-6. PubMed ID: 16742000
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.
Gardiner TA; Anderson HR; Stitt AW
J Pathol; 2003 Oct; 201(2):328-33. PubMed ID: 14517851
[TBL] [Abstract][Full Text] [Related]
5. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase.
Kanwar M; Chan PS; Kern TS; Kowluru RA
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3805-11. PubMed ID: 17652755
[TBL] [Abstract][Full Text] [Related]
6. Reduction of basement membrane thickening in diabetic cat retina by sulindac.
Mansour SZ; Hatchell DL; Chandler D; Saloupis P; Hatchell MC
Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):457-63. PubMed ID: 2318584
[TBL] [Abstract][Full Text] [Related]
7. Dilatation and endothelial proliferation of retinal capillaries in streptozotocin-diabetic rats: quantitative electron microscopy.
Sosula L; Beaumont P; Hollows FC; Jonson KM
Invest Ophthalmol; 1972 Nov; 11(11):926-35. PubMed ID: 4264069
[No Abstract] [Full Text] [Related]
8. Ultrastructural morphometry of capillary basement membrane thickness in normal and transgenic diabetic mice.
Carlson EC; Audette JL; Veitenheimer NJ; Risan JA; Laturnus DI; Epstein PN
Anat Rec A Discov Mol Cell Evol Biol; 2003 Apr; 271(2):332-41. PubMed ID: 12629676
[TBL] [Abstract][Full Text] [Related]
9. Increased basement membrane thickness, pericyte ghosts, and loss of retinal thickness and cells in dopamine beta hydroxylase knockout mice.
Steinle JJ; Kern TS; Thomas SA; McFadyen-Ketchum LS; Smith CP
Exp Eye Res; 2009 Jun; 88(6):1014-9. PubMed ID: 19176214
[TBL] [Abstract][Full Text] [Related]
10. C-peptide and retinal microangiopathy in diabetes.
Chakrabarti S; Khan ZA; Cukiernik M; Zhang W; Sima AA
Exp Diabesity Res; 2004; 5(1):91-6. PubMed ID: 15198374
[TBL] [Abstract][Full Text] [Related]
11. Tight glycemic control regulates fibronectin expression and basement membrane thickening in retinal and glomerular capillaries of diabetic rats.
Cherian S; Roy S; Pinheiro A; Roy S
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):943-9. PubMed ID: 18775856
[TBL] [Abstract][Full Text] [Related]
12. Retinal vascular changes induced by the oxidative stress of alpha-tocopherol deficiency contrasted with diabetic microangiopathy.
Robison WG; Jacot JL; Katz ML; Glover JP
J Ocul Pharmacol Ther; 2000 Apr; 16(2):109-20. PubMed ID: 10803422
[TBL] [Abstract][Full Text] [Related]
13. Significant retinal capillary basement membrane thickening in hyperglycemic and normoglycemic diabetic-prone (DP) BB Wistar rats.
Greenwood MD; Ressler MJ; Audette JL; Laturnus DI; Chhoun R; Teiken JM; Carlson EC
Ultrastruct Pathol; 2011 Apr; 35(2):97-105. PubMed ID: 21299351
[TBL] [Abstract][Full Text] [Related]
14. Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats.
Kojima K; Matsubara H; Harada T; Mizuno K; Suzuki M; Hotta N; Kakuta H; Sakamoto N
Jpn J Ophthalmol; 1985; 29(1):99-109. PubMed ID: 3159927
[TBL] [Abstract][Full Text] [Related]
15. Diabetic retinopathy: morphometric analysis of basement membrane thickening of capillaries in different retinal layers within arterial and venous environments.
Anderson HR; Stitt AW; Gardiner TA; Archer DB
Br J Ophthalmol; 1995 Dec; 79(12):1120-3. PubMed ID: 8562548
[TBL] [Abstract][Full Text] [Related]
16. Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve.
Robison WG; Nagata M; Tillis TN; Laver N; Kinoshita JH
Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2293-9. PubMed ID: 2509396
[TBL] [Abstract][Full Text] [Related]
17. Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.
Zheng Z; Chen H; Xu X; Li C; Gu Q
Exp Eye Res; 2007 Apr; 84(4):745-52. PubMed ID: 17303121
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor (PAI)-1 overexpression in retinal microvessels of PAI-1 transgenic mice.
Grant MB; Spoerri PE; Player DW; Bush DM; Ellis EA; Caballero S; Robison WG
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2296-302. PubMed ID: 10892876
[TBL] [Abstract][Full Text] [Related]
19. Remodeling of retinal capillaries in the diabetic hypertensive rat.
Dosso AA; Leuenberger PM; Rungger-Brändle E
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2405-10. PubMed ID: 10476809
[TBL] [Abstract][Full Text] [Related]
20. Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina.
Mrudula T; Suryanarayana P; Srinivas PN; Reddy GB
Biochem Biophys Res Commun; 2007 Sep; 361(2):528-32. PubMed ID: 17662242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]